However, in another randomized cross-over trial in patients with T2DM, acute treatment with linagliptin led to no significant change in BNP or NT-pro-BNP level compared to placebo in patients with or without chronic kidney disease. The gene discussed is NPPB; the disease is chronic kidney disease.